Results 41 to 50 of about 189,792 (145)
Pathophysiology of hyperuricemia and its clinical significance – a narrative review
Hyperuricemia, i.e. increased serum uric acid (UA) concentration, is a common problem in clinical practice. While there are clear guidelines concerning management of symptomatic hyperuricemia in acute conditions such as gout, urolithiasis or acute urate ...
Marta Skoczyńska +5 more
doaj +1 more source
Background Gout is a progressive disease due to Mono Sodium Urate (MSU) crystal deposition at joints, kidney, and other connective tissue, caused by chronic hyperuricemia.1 In both developed and developing countries, there were increasing prevalence ...
Cindy Oey +2 more
doaj +1 more source
BackgroundGout is a progressive metabolic disease closely related to hyperuricemia and urate deposition, with an increasing prevalence and incidence across the globe.
Hao Wu +8 more
doaj +1 more source
Asymptomatic Hyperuricemia and the Kidney: Lessons from the URRAH Study. [PDF]
Chronic kidney disease (CKD) is a prevalent global health concern affecting approximately 850 million people worldwide, with a significant and rising mortality rate.
Barnini C +7 more
europepmc +2 more sources
Objectives To explore pro‐inflammatory cytokines status in the tear fluid of patients with hyperuricemia and gout and its association with uric acid level.
Mian Wu +4 more
doaj +1 more source
Gout - asymptomatic hyperuricemia with/without asymptomatic monosodium urate crystal deposition: To be treated or not? [PDF]
Elevation of serum uric acid level without clinically visible arthritis (known as asymptomatic hyperuricemia) is not traditionally considered to be gout disease, but only a possible cause of it, even though it may be accompanied by tissue uric acid ...
Radak-Perović Marija +1 more
doaj +1 more source
Ultrasonography Profiles in Patients with Asymptomatic Hyperuricemia
Backgrounds: Asymptomatic hyperuricemia (AHU) patients mostly do not develop gouty arthritis. The best procedure to investigate whether they have MSU deposition has not been established.
Rahardjo, Paulus +4 more
core
Additional file 1: Figure S1. A 200-times permutation test for assessing the performance of PLS-DA model among control group, asymptomatic hyperuricemia, and gout. Table S1.
Shanshan Liu (315561) +3 more
core +1 more source
Yu-Qiang Zuo,1 Zhi-Hong Gao,1 Yu-Ling Yin,1 Xu Yang,1 Ping-Yong Feng2 1Department of Health Physical Examination Center, The 2nd Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China; 2Department of Imaging Center, The 2nd ...
Zuo YQ, Gao ZH, Yin YL, Yang X, Feng PY
doaj
Objective: To compare the frequency of low APGAR scores in babies born to normotensive patients with asymptomatic hyperuricemia with those without hyperuricemia. Study Design: Cohort Study.
Faryal Noman +4 more
doaj +1 more source

